Structural Formula (Roc04 0006 01)
Rocuronium Injection, Solution
Product Images NDC 65219-065
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rocuronium (NDC 65219-065). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Roc04 0006 02)
Figure 2 (Roc04 0006 03)
Figure 3 (Roc04 0006 04)
Fresenius Kabi Logo (Roc04 0006 05)
Package Label – Principal Display Panel – Rocuronium 5 mL Multiple Dose Vial Label (Roc04 0006 06)
This is a warning label for a pharmaceutical injectable product called "2605 Sterile". The product includes Rocuronium Bromide Injection, used as a paralyzing agent. It contains warnings of possible respiratory arrest, and the need for immediate artificial respiration facilities. Dosages and storage instructions are also included, including a warning not to freeze the product, and to use it within a limited timeframe after removal from refrigeration.*
Package Label – Principal Display Panel – Rocuronium 5 mL Multiple Dose Vial Tray Label (Roc04 0006 07)
Rocuronium is a paralyzing agent that is administered intravenously through sterilized multiple-dose vials. It can cause respiratory arrest, therefore facilities for artificial respiration must be immediately available. Each mL of the injection contains 10 mg of rocuronium bromide and 2 mg of sodium acetate. The injection should be stored at 2°C to 8°C and should not be frozen. Opened vials should be used within 30 days and unused injection, within 60 days of removal from refrigeration. The container closure does not contain any natural rubber latex. However, the rest of the text is illegible.*
Package Label (PRINCIPAL DISPLAY)
PARALYZING AGENT Peel off & apply - Rocuronium Bromide Injection contains 10 mg per mL and is intended for intravenous use only with a prescription. It is a paralyzing agent that can be applied after peeling off.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
